{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:33:45Z","timestamp":1787758425637,"version":"build-2784847793"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>\n                    We presented our observation with dexamethasone (DEX) implant in six eyes of three patients with Vogt\u2013Koyanagi\u2013Harada (VKH) disease who experienced hepatic dysfunction due to the systemic immunosuppressive therapy during their follow-up. Three cases who could not continue with the azathioprine (AZA) or adalimumab (ADA) treatment due to elevated liver enzymes were given consecutive bilateral DEX implant injections during the follow-up. In the first case\n                    <jats:bold>,<\/jats:bold>\n                    oral AZA was discontinued due to an elevation of the liver enzymes at the 2\n                    <jats:sup>nd<\/jats:sup>\n                    month of AZA treatment, and then she received five bilateral DEX implant administrations during the follow-up of 61 months without any intraocular pressure rise or disease recurrence. The remaining two patients had an elevation of the liver enzymes when ADA treatment was added to the prophylactic isoniazid therapy and they each received three bilateral DEX implant administrations within a year again without any complications and disease recurrence. DEX implant can be a safe and effective alternative for individuals with VKH disease whose systemic treatment is ceased due to adverse effects of the systemic treatment and intravitreal therapy with DEX implant can be beneficial to achieve a recurrence-free follow-up.\n                  <\/jats:p>","DOI":"10.4103\/2211-5056.357850","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T05:24:37Z","timestamp":1664861077000},"page":"543-547","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The place of dexamethasone implant in patients with Vogt\u2013Koyanagi\u2013Harada disease who experienced systemic treatment-related hepatic dysfunction: A case series"],"prefix":"10.4103","volume":"13","author":[{"given":"Ferdane","family":"Ata\u015f","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, \u00c7erkezk\u00f6y State Hospital, Tekirda\u011f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Kayaba\u015f\u0131","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Osman","family":"Saatci","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2016.05.002","article-title":"Vogt-Koyanagi-Harada disease","volume":"62","author":"O'Keefe","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ajo.2021.03.036","article-title":"Classification criteria for Vogt-Koyanagi-Harada disease","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"705796","DOI":"10.3389\/fmed.2021.705796","article-title":"New perspectives on the immunopathogenesis and treatment of uveitis associated with Vogt-Koyanagi-Harada disease","volume":"8","author":"Abu El-Asrar","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"e27394","DOI":"10.1097\/MD.0000000000027394","article-title":"Efficacy of intravitreal dexamethasone implant in patients with Vogt-Koyanagi-Harada disease and bilateral panuveitis: Two case reports","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R5-20240830","first-page":"1423","article-title":"Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant","volume":"4","author":"Myung","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10067-014-2623-1","article-title":"Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis","volume":"34","author":"Latronico","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R8-20240830","first-page":"1613","article-title":"Dexamethasone intravitreal implant for the treatment of noninfectious uveitis","volume":"5","author":"Hunter","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R9-20240830","first-page":"169","article-title":"Intravitreal dexamethasone implant in the treatment of non-infectious uveitic macular edema","volume":"7","author":"Karti","year":"2018","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000442346","article-title":"Simultaneous single dexamethasone implant and ranibizumab injection in a case with active serpiginous choroiditis and choroidal neovascular membrane","volume":"6","author":"Saatci","year":"2015","journal-title":"Case Rep Ophthalmol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/2211-5056.357850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:16:38Z","timestamp":1787757398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2211-5056.357850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/2211-5056.357850","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"2022-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}